DOXAZOSIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Doxazosin, and what generic alternatives are available?
Doxazosin is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Ani Pharms, Apotex, Aurobindo Pharma Usa, Chartwell Rx, Genpharm, Heritage Pharma, Ivax Sub Teva Pharms, Nesher Pharms, Pliva, Rising, Somerset Theraps Llc, Strides Pharma Intl, Teva, Unichem, Watson Labs Inc, and Zydus Pharms. and is included in nineteen NDAs.
The generic ingredient in DOXAZOSIN is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxazosin
A generic version of DOXAZOSIN was approved as doxazosin mesylate by APOTEX on October 18th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOXAZOSIN?
- What are the global sales for DOXAZOSIN?
- What is Average Wholesale Price for DOXAZOSIN?
Summary for DOXAZOSIN
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 19 |
| Drug Prices: | Drug price information for DOXAZOSIN |
| Drug Sales Revenues: | Drug sales revenues for DOXAZOSIN |
| What excipients (inactive ingredients) are in DOXAZOSIN? | DOXAZOSIN excipients list |
| DailyMed Link: | DOXAZOSIN at DailyMed |
